Author/Creator: Colombel, J F - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Colombel, J F

21. DOP38 Upadacitinib Therapy Reduces Crohn's Disease Symptoms Within the First Week of Induction Therapy. (30th January 2023)

Authors:: Colombel, J F; Hisamatsu, T; Bresso, F; Thin, L; Parra, R; Ford, S; Remple, V; Lacerda, A P; Hecht, P; Mallick, M; Garrison, A; Regueiro, M
Journal:: Journal of Crohn's and colitis
Issue:: Volume 17(2023)Supplement 1
Page Start:: i102
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

22. DOP38 Upadacitinib Therapy Reduces Ulcerative Colitis Symptoms as Early as Day 1. (21st January 2022)

Authors:: Vermeire, S; Colombel, J F; Takeuchi, K; Gao, X; Panaccione, R; Danese, S; Dubinsky, M; Schreiber, S; Ilo, D; Finney-Hayward, T; Zhou, W; Phillips, C; Yao, X; Zhou, Q; Loftus, E
Journal:: Journal of Crohn's and colitis
Issue:: Volume 16(2022)Supplement 1
Page Start:: i087
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

23. DOP39 Effect of baseline disease characteristics on clinical outcomes in moderate-to-severe Ulcerative Colitis treated with upadacitinib: Results from a Phase 3 trials programme. (21st January 2022)

Authors:: Higgins, P; Colombel, J F; Reguiero, M; Parkes, G; Ilo, D; Philips, C; Yao, X; Cheng, E; Schreiber, S
Journal:: Journal of Crohn's and colitis
Issue:: Volume 16(2022)Supplement 1
Page Start:: i088
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

24. DOP39 Endoscopic, histologic, and combined outcomes with reinitiation of ozanimod after temporary discontinuation: 2-year interim analysis of the True North open-label extension study. (30th January 2023)

Authors:: Vermeire, S; Dignass, A; Colombel, J F; Jain, A; Canavan, J B; Wu, H; Lawlor, G; Osterman, M T; Rubin, D T; Regueiro, M
Journal:: Journal of Crohn's and colitis
Issue:: Volume 17(2023)Supplement 1
Page Start:: i103
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

25. DOP43 Extended induction in the True North OLE study: ozanimod efficacy in biologic-naive and biologic-experienced patients. (30th January 2023)

Authors:: Dignass, A; Regueiro, M; Colombel, J F; Jain, A; Canavan, J B; Wu, H; Lawlor, G; Osterman, M T; Vermeire, S; Rubin, D T
Journal:: Journal of Crohn's and colitis
Issue:: Volume 17(2023)Supplement 1
Page Start:: i110
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

26. DOP44 Long-term use of ozanimod in patients with moderately to severely active Ulcerative Colitis. (21st January 2022)

Authors:: Danese, S; Colombel, J F; Ponich, T; Jovanovic, I; Bossuyt, P; Longman, R; Alekseeva, O; Petersen, A; Chitkara, D; Marta, C; Charles, L; Rubin, D T; Afzali, A; Loftus, E V; Wolf, D C
Journal:: Journal of Crohn's and colitis
Issue:: Volume 16(2022)Supplement 1
Page Start:: i093
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

27. DOP58 Non-white race is associated with decreased efficacy of tumor necrosis factor antagonist therapy in Ulcerative Colitis: A post-hoc analysis of individual level data from golimumab clinical trials. (27th May 2021)

Authors:: Greywoode, R; Petralia, F; Ullman, T; Colombel, J F; Ungaro, R
Journal:: Journal of Crohn's and colitis
Issue:: Volume 15(2021)Supplement 1
Page Start:: S093
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

28. DOP59 Development of a novel Ulcerative Colitis (UC) endoscopic activity prediction model using machine learning (ML). (21st January 2022)

Authors:: Colombel, J F; Rubin, D; Schott, J P; Gottlieb, K; Erisson, L; Prucka, B; Phillips, S; Kwon, J; Ng, J; McGill, J
Journal:: Journal of Crohn's and colitis
Issue:: Volume 16(2022)Supplement 1
Page Start:: i105
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

29. DOP62 Medication use is increased in the decade prior to IBD diagnosis: A nationwide cohort study. (30th January 2023)

Authors:: Bonfils, L; Karachalia Sandri, A; Juul Poulsen, G; Agrawal, M; Ward, D J; Jess, T; Colombel, J F; Allin, K H
Journal:: Journal of Crohn's and colitis
Issue:: Volume 17(2023)Supplement 1
Page Start:: i136
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

30. DOP69 Glycans as an actor in the microbiome-immune response crosstalk. (30th January 2023)

Authors:: Rodrigues, C; Gaifem, J; Pereira, M; Lavelle, A; Colombel, J F; Sokol, H; Pinho, S
Journal:: Journal of Crohn's and colitis
Issue:: Volume 17(2023)Supplement 1
Page Start:: i145
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗